Convalescent Plasma for COVID-19. A randomized clinical trial

Arvind Gharbharan, Carlijn C.E. Jordans, Corinne Geurtsvankessel, Jan G. den Hollander, Faiz Karim, Femke P. N. Mollema, Janneke E. Stalenhoef-Schukken, Anthonius Dofferhoff, Inge Ludwig, Adrianus Koster, Robert-Jan Hassing, Jeannet C. Bos, Geert R. van Pottelberge, Imro N. Vlasveld, Heidi S. M. Ammerlaan, Elena M. van Leeuwen-Segarceanu, Jelle Miedema, Menno van der Eerden, Grigorios Papageorgiou, Peter te Boekhorst, Francis H. Swaneveld, Peter D. Katsikis, Yvonne Mueller, Nisreen M.A. Okba, Marion P.G. Koopmans, Bart H.G. Haagmans, Casper Rokx, Bart J.A. Rijnders
doi: https://doi.org/10.1101/2020.07.01.20139857

Article Information

doi 
https://doi.org/10.1101/2020.07.01.20139857
History 
  • July 3, 2020.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Arvind Gharbharan*,1,
  2. Carlijn C.E. Jordans*,1,
  3. Corinne Geurtsvankessel1,
  4. Jan G. den Hollander,
  5. Faiz Karim3,
  6. Femke P. N. Mollema4,
  7. Janneke E. Stalenhoef-Schukken5,
  8. Anthonius Dofferhoff6,
  9. Inge Ludwig7,
  10. Adrianus Koster8,
  11. Robert-Jan Hassing9,
  12. Jeannet C. Bos10,
  13. Geert R. van Pottelberge11,
  14. Imro N. Vlasveld12,
  15. Heidi S. M. Ammerlaan13,
  16. Elena M. van Leeuwen-Segarceanu14,
  17. Jelle Miedema1,
  18. Menno van der Eerden1,
  19. Grigorios Papageorgiou1,
  20. Peter te Boekhorst1,
  21. Francis H. Swaneveld15,
  22. Peter D. Katsikis1,
  23. Yvonne Mueller1,
  24. Nisreen M.A. Okba1,
  25. Marion P.G. Koopmans1,
  26. Bart H.G. Haagmans1,
  27. Casper Rokx*,1 and
  28. Bart J.A. Rijnders*,1,†
  1. 1Erasmus MC, University Medical Center, Rotterdam, the Netherlands
  2. 2Maasstad Hospital, Rotterdam, the Netherlands
  3. 3Groene Hart Hospital, Gouda, the Netherlands
  4. 4Haaglanden Medical Center, The Hague, the Netherlands
  5. 5Onze Lieve Vrouwen Hospital, Amsterdam, the Netherlands
  6. 6Canisius Wilhelmina Hospital, Nijmegen, the Netherlands
  7. 7Bernhoven Hospital, Uden, the Netherlands
  8. 8Viecurie Medical Center, Venlo, the Netherlands
  9. 9Rijnstate Hospital, Arnhem, the Netherlands
  10. 10Reinier de Graaf Gasthuis, Delft, the Netherlands
  11. 11ZorgSaam Hospital, Terneuzen, the Netherlands
  12. 12Martini Hospital, Groningen, the Netherlands
  13. 13Catharina Hospital, Eindhoven, the Netherlands
  14. 14Sint Antonius Hospital, Nieuwegein, the Netherlands
  15. 15Unit of Transfusion Medicine, Sanquin Blood Supply, Amsterdam, the Netherlands
  1. ↵† Corresponding author; email: b.rijnders{at}erasmusmc.nl

  1. ↵* Contributed equally as first and last author

Back to top
Posted July 03, 2020.
Download PDF

Supplementary Material

Data/Code
Email
Convalescent Plasma for COVID-19. A randomized clinical trial
Arvind Gharbharan, Carlijn C.E. Jordans, Corinne Geurtsvankessel, Jan G. den Hollander, Faiz Karim, Femke P. N. Mollema, Janneke E. Stalenhoef-Schukken, Anthonius Dofferhoff, Inge Ludwig, Adrianus Koster, Robert-Jan Hassing, Jeannet C. Bos, Geert R. van Pottelberge, Imro N. Vlasveld, Heidi S. M. Ammerlaan, Elena M. van Leeuwen-Segarceanu, Jelle Miedema, Menno van der Eerden, Grigorios Papageorgiou, Peter te Boekhorst, Francis H. Swaneveld, Peter D. Katsikis, Yvonne Mueller, Nisreen M.A. Okba, Marion P.G. Koopmans, Bart H.G. Haagmans, Casper Rokx, Bart J.A. Rijnders
medRxiv 2020.07.01.20139857; doi: https://doi.org/10.1101/2020.07.01.20139857
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area